MedPath

To assess the efficacy of mycophenolate mofetil in acquired dermatoses with dermal hyperpigmentation.

Not Applicable
Completed
Conditions
Health Condition 1: null- Lichen planus pigmentosus/ Acquired dermal macular hyperpigmentation
Registration Number
CTRI/2018/06/014650
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

Patients with a cliniopathological diagnosis of acquired dermal macular hyperpigmentation.

1. Age >18 years.

2. Consenting for inclusion in the study

Exclusion Criteria

1. Age < 18 years.

2. Pregnancy/Lactation

3. Patients with severe hepatic, renal disease or dyslipidemia

4. Pre existing malignancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath